Details of the Drug

General Information of Drug (ID: DMVTTBZ)

• Drug Name: mRNA-4157

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 2	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: DTY5W0
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03897881) An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942). U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)